Valuing health for regulatory cost-effectiveness analysis /
نام عام مواد
[Book]
نام نخستين پديدآور
Wilhelmine Miller, Lisa A. Robinson, and Robert S. Lawrence, editors ; Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation, Board on Health Care Services, Institute of Medicine of the National Academies.
یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
Characteristics of major regulations and current analytic practices -- Measures and strategies for obtaining health benefit values for regulatory analysis -- Beyond ratios: ethical and nonquantifiable aspects of regulatory decisions -- Recommendations for regulatory cost-effectiveness analysis.
بدون عنوان
0
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Promoting human health and safety by reducing exposures to risks and harms through regulatory interventions is among the most important responsibilities of the government. Such efforts encompass a wide array of activities in many different contexts: improving air and water quality; safeguarding the food supply; reducing the risk of injury on the job, in transportation, and from consumer products; and minimizing exposure to toxic chemicals. Estimating the magnitude of the expected health and longevity benefits and reductions in mortality, morbidity, and injury risks helps policy makers decide whether particular interventions merit the expected costs associated with achieving these benefits and inform their choices among alternative strategies. Valuing Health for Regulatory Cost-Effectiveness Analysis provides useful recommendations for how to measure health-related quality of- life impacts for diverse public health, safety, and environmental regulations. Public decision makers, regulatory analysts, scholars, and students in the field will find this an essential review text. It will become a standard reference for all government agencies and those consultants and contractors who support the work of regulatory programs.
ویراست دیگر از اثر در قالب دیگر رسانه
عنوان
Valuing health for regulatory cost-effectiveness analysis.
شماره استاندارد بين المللي کتاب و موسيقي
0309100771
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Cost effectiveness.
موضوع مستند نشده
Medical care-- Cost effectiveness-- Research-- Methodology.
موضوع مستند نشده
Cost-Benefit Analysis, methods-- United States.
موضوع مستند نشده
Health Policy-- economics-- United States.
موضوع مستند نشده
United States Government Agencies-- United States.
موضوع مستند نشده
Cost effectiveness.
موضوع مستند نشده
MEDICAL-- Administration.
موضوع مستند نشده
MEDICAL-- Practice Management & Reimbursement.
مقوله موضوعی
موضوع مستند نشده
MED-- 002000
موضوع مستند نشده
MED-- 095000
رده بندی ديویی
شماره
362
.
1068/1
ويراست
22
رده بندی کنگره
شماره رده
RA410
.
5
نشانه اثر
.
V35
2006eb
سایر رده بندی ها
شماره رده
WA
540
AA1
نشانه اثر
V215
2006
نام شخص - (مسئولیت معنوی برابر )
مستند نام اشخاص تاييد نشده
Lawrence, Robert S.,1938-
مستند نام اشخاص تاييد نشده
Miller, Wilhelmine.
مستند نام اشخاص تاييد نشده
Robinson, Lisa A.
نام تنالگان _ (مسئولیت معنوی برابر)
مستند نام تنالگان تاييد نشده
Institute of Medicine (U.S.)., Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation.